Evidence map›Paper›PMID 40382690›Full record

ArticleArchives of Iranian medicine2025

Investigating the Trend of Mortality, Life Expectancy and Excessive Death with Emphasis on the Role of the COVID-19 Pandemic Period in the Isfahan Province: A Cross-sectional Study of Join Point Regression Analysis 2011-2021.

Maziyar Mollaei Pardeh, Mohammad Hossein Yarmohammadian, Habibollah Azarbakhsh, Golrokh Atighechian, Afshin Ebrahimi, Andishe Hamedi, Mohamad Reza Maracy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Iranian medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maziyar Mollaei PardehDepartment of Health in Emergencies, Social Determinants of Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0009-0000-9149-0866
Mohammad Hossein YarmohammadianDepartment of Health in Emergencies, Health Management and Economic Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Habibollah AzarbakhshDepartment of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Golrokh AtighechianSocial Determinants of Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Afshin EbrahimiDepartment of Environmental Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Andishe HamediStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohamad Reza MaracyDepartment of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-3695-0863

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComparing the trends of mortality rates provides valuable insight for policy discussions and promotes awareness of health issues. This study aimed to investigate the changes in mortality rate and life expectancy from 2011 to 2021 and the effect of COVID-19 period on these indices.

methodsWe investigated the data of all-cause deaths between 2011 and 2021 by age group, sex and year using Excel spreadsheets from the National Organization for Civil Registration (NOCR), via collected the census method. Joinpoint regression was used to calculate the trend of mortality rate during the study period.

resultsDuring the study period, there were 262,708 deaths, of which 148,919 were men (56.68%). The trend of mortality rate in both sexes has been increasing. Life expectancy in men and women decreased from 76.71 and 80.82 in 2011 to 74.43 and 77.53 in 2021, respectively. From 2018 to 2021, there was a significant increase in standardized mortality rate in men (APC=14.74; 95% CI=5.73; 28.65) and women (APC=14.29; 95% CI=4.67; 28.97). However, from 2011 to 2018, we observed a yearly 2.65% decreasing trend in men which was statistically significant (APC=-2.95, 95% CI=-7.67, -0.84). In women, no significant trend was seen.

conclusionWith the emergence of the COVID-19 epidemic in 2019, the trend of mortality rate and life expectancy changed completely, with additional deaths and decreasing life expectancy. Therefore, prevention, control and treatment of epidemic diseases should be a serious concern of policy makers.

Indexed as

COVID-19Life ExpectancyMortalityAdolescentAdultAgedAged, 80 and overCause of DeathChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornIranCOVID-19Excessive deathIranJoinpoint regressionMortality rate

Identifiers

PMID40382690
PMCPMC12085798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.